v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net Income (Loss) $ (5,879) $ (56,609)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 15,142 18,931
Share-based compensation expense 120,997 115,714
Non-cash operating lease expense 7,409 6,432
Net amortization of premium or discount on investments (2,264) (4,197)
Gains on foreign exchange (1,916) (677)
Changes in operating assets and liabilities:    
Accounts receivable (16,994) (13,922)
Prepaid expenses and other assets (14,317) (2,973)
Deferred contract acquisition costs (24,260) (6,661)
Accounts payable 1,315 6,712
Accrued expenses and other liabilities 9,934 4,301
Operating lease liabilities (5,063) (6,550)
Deferred revenue 80,622 34,533
Net cash provided by operating activities 164,726 95,034
Cash flows from investing activities:    
Purchases of short-term investments (555,658) (443,217)
Maturities of short-term investments 377,348 349,080
Purchases of property and equipment (7,200) (2,620)
Net cash used in investing activities (185,510) (96,757)
Cash flows from financing activities:    
Proceeds from exercise of share options 5,945 9,971
Proceeds from employee share purchase plan 14,651 11,917
Proceeds from employee equity transactions, net of payments to tax authorities and employees 1,916 7,300
Repurchases of ordinary shares (2,028) 0
Net cash provided by financing activities 20,484 29,188
Effect of exchange rate changes on cash, cash equivalents and restricted cash (751) 1,021
Net increase (decrease) in cash, cash equivalents, and restricted cash (1,051) 28,486
Cash, cash equivalents, and restricted cash—beginning of period 76,551 50,627
Cash, cash equivalents, and restricted cash—end of period $ 75,500 $ 79,113